CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-05 | Barrans Russell Chief Commercial Officer | Grant or award | +150,000 | 347,197 | ||
| 2020-02-05 | Barrans Russell Chief Commercial Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2020-02-05 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award | +3,846 | $5.21 | $20K | 366,135 |
| 2020-02-05 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award | +300,000 | 666,135 | ||
| 2020-02-05 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock option (right to buy) | +300,000 | 300,000 | ||
| 2020-02-05 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award | +150,000 | 213,331 | ||
| 2020-02-05 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2020-02-05 | File Justin J. Chief Financial Officer | Grant or award | +3,846 | $5.21 | $20K | 181,097 |
| 2020-02-05 | File Justin J. Chief Financial Officer | Grant or award | +150,000 | 331,097 | ||
| 2020-02-05 | File Justin J. Chief Financial Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2020-02-05 | Culwell Kelly Chief Medical Officer | Grant or award | +3,688 | $5.21 | $19K | 47,226 |
| 2020-02-05 | Culwell Kelly Chief Medical Officer | Grant or award | +150,000 | 197,226 | ||
| 2020-02-05 | Culwell Kelly Chief Medical Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2020-01-16 | Barrans Russell Chief Commercial Officer | Sale | −1,578 | $6.50 | $10K | 196,298 |
| 2020-01-13 | File Justin J. Chief Financial Officer | Sale | −1,648 | $6.00 | $10K | 177,251 |
| 2020-01-13 | PELLETIER SAUNDRA L Chief Executive Officer | Sale | −3,295 | $6.00 | $20K | 362,289 |
| 2020-01-02 | PELLETIER SAUNDRA L Chief Executive Officer | Sale | −6,705 | $6.05 | $41K | 365,584 |
| 2020-01-02 | File Justin J. Chief Financial Officer | Sale | −3,352 | $6.05 | $20K | 178,899 |
| 2019-12-31 | Lynch Thomas G Director | Option exercise | +37,500 | 287,500 | ||
| 2019-12-31 | Lynch Thomas G Director | Option exercise · Restricted Stock Units | −37,500 | 37,500 |
Page 6 of 20 · 383 trades